Research progress of influenza vaccination, pneumococcal vaccination and COVID-19 vaccination among cancer patients / 中华预防医学杂志
Chinese Journal of Preventive Medicine
;
(12): 100-106, 2023.
Article
Dans Chinois
| WPRIM
| ID: wpr-969850
ABSTRACT
This article reviews the relevant studies on the efficacy and safety of influenza, pneumococcal and COVID-19 vaccination among tumor patients worldwide in recent years. By combing and analyzing the retrieved literature, the results show that influenza and pneumococcal vaccination can significantly reduce the morbidity and hospitalization rate of infectious diseases in tumor patients, reduce the risk of cardiovascular events and death, and significantly improve survival prognosis. COVID-19 vaccination can also protect tumor patients, especially those who have completed full dose vaccination. Authoritative guidelines and consensuses worldwide all recommend that tumor patients receive influenza, pneumococcal and COVID-19 vaccines. We should carry out relevant researches, as well as take effective measures to strengthen patient education, so that tumor patients can fully experience the health protection brought by the vaccine to this specific group.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Streptococcus pneumoniae
/
Vaccins antigrippaux
/
Vaccination
/
Vaccins antipneumococciques
/
Grippe humaine
/
Vaccins contre la COVID-19
/
COVID-19
/
Tumeurs
Limites du sujet:
Humains
langue:
Chinois
Texte intégral:
Chinese Journal of Preventive Medicine
Année:
2023
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS